Ensysce Biosciences, Inc. (ENSC) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Ensysce Biosciences, Inc. (ENSC) closed at USD 0.56 on 2026-10-14, a change of -73.4 % over the past year, with a market capitalization of USD 11.63M.

Ensysce Biosciences, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Ensysce Biosciences, Inc. key figures

Previous close

USD 0.56 (2026-10-14)

1-year change

-73.4 %

Market cap

USD 11.63M

Enterprise value

USD 10.82M

P/E ratio (trailing)

-0.24

P/E ratio (forward)

-11.96

EPS (trailing)

-2.50

EPS (forward)

-0.05

PEG ratio

n/a

Price to book

-12.46

Revenue growth

-15.1 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.14

Employees

8

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company's lead product candidate is PF614, a TAAP oxycodone prodrug candidate for the treatment of severe or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection. It is also developing PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for attention deficit hyperactivity disorder; and PF9001 to treat opioid use disorder. Further, It develops neuroplastogenic therapies and psychedelic-derived molecules for severe chronic pain, particularly complex regional pain syndrome (CRPS). Ensysce Biosciences, Inc. was founded in 2003 and is based in La Jolla, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Ensysce Biosciences, Inc. and compare it with other stocks.